Lyell Immunopharma, Inc. (LYEL)

NASDAQ: LYEL · Real-Time Price · USD

13.17

+0.19 (1.50%)

Jul 30, 2026, 11:54 AM EDT - Market open

Lyell Immunopharma Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.03	0.04	0.06	0.13	84.68	10.65
Revenue Growth	-52.31%	-40.98%	-53.08%	-99.85%	695.15%	37.31%
Gross Profit	0.03	0.04	0.06	0.13	84.68	10.65
Operating Income	-256.3	-269.4	-358.76	-247.01	-187.06	-214.78
Net Income	-246.41	-274.45	-342.99	-234.63	-183.12	-250.22
Earnings Per Share	-13.80	-16.06	-26.23	-18.70	-14.80	-36.80
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	254.02	247.22	370.53	546.22	640.15	614.79
Total Debt	39.49	41.92	50.99	56.89	63.17	66.65
Net Cash (Debt)	214.54	205.3	319.53	489.33	576.98	548.14
Net Cash Growth	-14.98%	-35.75%	-34.70%	-15.19%	5.26%	-2.41%
Net Cash Per Share	11.37	12.01	24.44	38.99	46.70	80.66

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-133.8	-150.02	-162.39	-163.69	-169.56	-126.25
Capital Expenditures	-0.62	-0.78	-0.46	-2.69	-24.28	-65.5
Free Cash Flow	-134.42	-150.8	-162.86	-166.38	-193.83	-191.75
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-826768.00%	-748344.00%	-588123.00%	-190006.00%	-220.89%	-2016.68%
Pretax Margin	-794858.06%	-762355.56%	-562285.25%	-180486.15%	-216.24%	-2349.47%
Profit Margin	-794858.00%	-762356.00%	-562285.00%	-180486.00%	-216.24%	-2349.47%
FCF Margin	-433610.00%	-418900.00%	-266980.00%	-127985.00%	-228.89%	-1800.50%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	10252.31	18169.60	3093.82	3789.86	10.23	176.41